James Cheng-Chung WeiSteering Committee Member

James Cheng-Chung Wei is Professor of Institute of Medicine, Chung Shan Medical University and Vice Superintendent and Director of the Clinical Trial Center of Chung Shan Medical University Hospital, Taichung, TW.  

After his training in rheumatology and clinical immunology at Taichung and Kaohsiung Veterans General Hospital, Professor Wei undertook a fellowship at the Royal National Hospital for Rheumatic Diseases, Bath, UK, under Professor Andrei Calin. He pursued a research fellowship at the University of California, Los Angeles, US, under Professor David Yu, investigating the pathogenesis of spondylarthritis.   

He has published 400+ articles in SCI journals, such as the NEJM, JAMA, Lancet, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, International Journal of Epidemiology, and Rheumatology. He had been the principal investigator of more than 150 global clinical trials and PI-initiated studies. He is currently the Editor-in-Chief of the International Journal of Rheumatic Diseases and Associate Editor of Frontiers in Immunology and Frontiers in Pharmacology.  

His major interests are translational research in ankylosing spondylitis, clinical trials and big data epidemiological studies.